This listing has expired.
Recent Posts
- Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer
- Corporate Update – IND for MagSense® HER2 Phase 2 Study Immediate Priority
- Successful Placement of A$3M
- [Video] Shareholder Webinar Recording | August 15, 2024
- Imagion Biosystems Announces Shareholder Webinar
Categories
- News (258)
- Investor updates (376)
- Scientific Publications (10)
- Press & Media (18)
- Events & Webinars (25)
- Company Update (18)
- Newsletters (9)